These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1889222)

  • 1. Phosphatic metabolism and corneal edema.
    Lass JH; Greiner JV; Reinhart WJ; Medcalf SK; Glonek T
    Cornea; 1991 Jul; 10(4):346-53. PubMed ID: 1889222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix and Na+,K+-ATPase in human corneas following cataract surgery: comparison with bullous keratopathy and Fuchs' dystrophy corneas.
    Ljubimov AV; Atilano SR; Garner MH; Maguen E; Nesburn AB; Kenney MC
    Cornea; 2002 Jan; 21(1):74-80. PubMed ID: 11805512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft survival in four common groups of patients undergoing penetrating keratoplasty.
    Price FW; Whitson WE; Marks RG
    Ophthalmology; 1991 Mar; 98(3):322-8. PubMed ID: 2023753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrating keratoplasty: changing indications, 1947 to 1978.
    Smith RE; McDonald HR; Nesburn AB; Minckler DS
    Arch Ophthalmol; 1980 Jul; 98(7):1226-9. PubMed ID: 6994703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of phosphate metabolites of the ocular humors.
    Greiner JV; Chanes LA; Glonek T
    Ophthalmic Res; 1991; 23(2):92-7. PubMed ID: 1870846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of aquaporins in bullous keratopathy and Fuchs' dystrophy corneas.
    Kenney MC; Atilano SR; Zorapapel N; Holguin B; Gaster RN; Ljubimov AV
    J Histochem Cytochem; 2004 Oct; 52(10):1341-50. PubMed ID: 15385580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for penetrating keratoplasty: 1980-1988.
    Lindquist TD; McGlothan JS; Rotkis WM; Chandler JW
    Cornea; 1991 May; 10(3):210-6. PubMed ID: 2055026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual results after penetrating keratoplasty for aphakic bullous keratopathy and Fuchs' dystrophy.
    Olson RJ; Waltman SR; Mattingly TP; Kaufman HE
    Am J Ophthalmol; 1979 Dec; 88(6):1000-4. PubMed ID: 391046
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of donor and recipient factors on corneal graft rejection.
    Stulting RD; Sugar A; Beck R; Belin M; Dontchev M; Feder RS; Gal RL; Holland EJ; Kollman C; Mannis MJ; Price F; Stark W; Verdier DD;
    Cornea; 2012 Oct; 31(10):1141-7. PubMed ID: 22488114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53, CD95, cathepsin and survivin pathways in Fuchs' dystrophy and pseudophakic bullous keratopathy corneas.
    Szentmáry N; Szende B; Süveges I
    Histol Histopathol; 2008 Aug; 23(8):911-6. PubMed ID: 18498065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial cell, keratocyte, and endothelial cell apoptosis in Fuchs' dystrophy and in pseudophakic bullous keratopathy.
    Szentmáry N; Szende B; Süveges I
    Eur J Ophthalmol; 2005; 15(1):17-22. PubMed ID: 15751234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient risk factors for graft failure in the cornea donor study.
    Sugar A; Tanner JP; Dontchev M; Tennant B; Schultze RL; Dunn SP; Lindquist TD; Gal RL; Beck RW; Kollman C; Mannis MJ; Holland EJ;
    Ophthalmology; 2009 Jun; 116(6):1023-8. PubMed ID: 19395036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudophakic keratoplasty].
    Freyler H
    Klin Monbl Augenheilkd; 1986 Feb; 188(2):105-7. PubMed ID: 3520118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of visual acuity after penetrating keratoplasty.
    Price FW; Whitson WE; Marks RG
    Ophthalmology; 1991 Aug; 98(8):1177-85. PubMed ID: 1923353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal grafts for endothelial decompensation: the influence of intraocular lenses on corneal graft survival.
    Völker-Dieben HJ; Kok-van Alphen CC; de Lange P
    Acta Ophthalmol (Copenh); 1984 Jun; 62(3):432-44. PubMed ID: 6380202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988.
    Brady SE; Rapuano CJ; Arentsen JJ; Cohen EJ; Laibson PR
    Am J Ophthalmol; 1989 Aug; 108(2):118-22. PubMed ID: 2667369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy.
    Rosenbaum JT; Planck ST; Huang XN; Rich L; Ansel JC
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2151-5. PubMed ID: 7657553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous humor protein and complement in pseudophakic eyes.
    Tuberville AW; Wood TO
    Cornea; 1990 Jul; 9(3):249-53. PubMed ID: 2373019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Descemet's Membrane Endothelial Keratoplasty for Fuchs Endothelial Dystrophy versus Bullous Keratopathy: Histopathology and Clinical Results.
    Brockmann T; Brockmann C; Maier AB; Schroeter J; Bertelmann E; Torun N
    Curr Eye Res; 2018 Oct; 43(10):1221-1227. PubMed ID: 29939775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving indications for and trends in keratoplasty in British Columbia, Canada, from 2002 to 2011: a 10-year review.
    Tan JC; Holland SP; Dubord PJ; Moloney G; McCarthy M; Yeung SN
    Cornea; 2014 Mar; 33(3):252-6. PubMed ID: 24457452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.